The brain accounts for only 2% of body weight but consumes 20% of the body's total energy, making it highly vulnerable to impaired glucose metabolism.
Snapshot · Mind Pump: Raw Fitness Truth
The brain accounts for only 2% of body weight but consumes 20% of the body's total energy, making it highly vulnerable to impaired glucose metabolism.
Where this was said
At 43:20 · chapter starts 42:58
Sal shifts to a health news item: Science News has published new findings connecting diabetes to a 60% elevated dementia risk, grounded in the biology of glucose metabolism. The brain is just 2% of body weight but consumes 20% of the body's energy. [1] — Sal Di Stefano "Diabetes raises dementia risk 60%: A new study cited in Science News found that diabetes increases the risk of dementia by 60%, linked to t…" 42:54 When diabetes impairs the ability of brain cells to use glucose effectively, the result is accelerated cognitive decline. This same mechanism explains a puzzling clinical observation: people with dementia or Alzheimer's often improve symptomatically on ketogenic diets, because their brains can still metabolize ketones even when glucose pathways are failing. [2] — Sal Di Stefano "Strength training: best dementia prevention: Strength training is the most effective exercise for preventing dementia and Alzheimer's becau…" 43:40 Sal's punchline: the most effective preventive intervention is strength training, because building muscle is the single most powerful lever for improving insulin sensitivity — making the body's energy delivery to the brain more efficient before damage accumulates. Justin connects this to his own family history of dementia and his efforts to encourage his mother toward better habits.
Strength training is the most effective exercise for preventing dementia and Alzheimer's because building muscle improves insulin sensitivity, the body's primary carbohydrate storage mechanism.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.